Lupin Says Looked At Wockhardt, But No Acquisition Talks
This article was originally published in PharmAsia News
Executive Summary
Lupin acknowledges it has looked into the possibility of acquiring troubled Wockhardt, but says the interest has gone no farther than that and the two India drug makers are not in talks.